Dimericon Therapeutics is a startup based in Germany.
Dimericon Therapeutics develops small molecule drugs by leveraging novel chemical scaffolds and innovative drug discovery approaches to target difficult biomedical challenges.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.